戻る Agenda
Pharmaceutical Project Management: What's Really Important and How Can We Do Better?
Session Chair(s)
John Z. Sun, PHD, MBA, PMP
Program Lead, Portfolio, Strategy & Operations, CRM DU, Development
Novartis, United States
Project management (PM) plays an important role in pharma and biotech companies, but what can we do to further improve, particularly in today's environment? Come and hear the critical findings from a panel of PM practitioners and experts.
This session has been developed by the Project Management Community.
Learning Objective : Discuss which project management practices are more critical to be focused on to ensure project success in the pharmaceutical and biotechnology industry; Recognize what we can learn from other industries and do better for your own teams with innovative solutions.
Speaker(s)
Managing Complex Product Development Projects
Peter Harpum, PHD, MSC
Mannaz A/S, United Kingdom
Client Director
The Five Core Qualities of Authentic Leaders
Robin G Foldesy, PHD
Quintiles Transnational Corp., United States
Vice President, Strategic Drug Development
Meeting the Challenges of Managing Teams and Alliances
Mary Lou Bell
Nimbus Discovery, United States
Head, Portfolio and Program Management